AC Immune Ltd (ACIU) — Cash Flow-to-Debt Ratio
AC Immune Ltd (ACIU) has a Cash Flow-to-Debt Ratio of -0.15x as of December 2025, meaning its operating cash flow of $-16.45 Million could theoretically repay 0% of its total liabilities ($109.49 Million) in one year. See ACIU FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
AC Immune Ltd Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for AC Immune Ltd across 13 annual periods. Also explore how fast is AC Immune Ltd growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for AC Immune Ltd (2013–2025)
Year-by-year debt coverage analysis for AC Immune Ltd. For market capitalisation and broader financial context, see ACIU company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.60x | $-66.15 Million | $109.49 Million | ▼ -208.9% |
| 2024 | 0.55x | $65.84 Million | $118.64 Million | ▲ +120.4% |
| 2023 | -2.72x | $-60.41 Million | $22.17 Million | ▲ +37.2% |
| 2022 | -4.34x | $-73.57 Million | $16.95 Million | ▼ -94.7% |
| 2021 | -2.23x | $-65.69 Million | $29.46 Million | ▲ +12.9% |
| 2020 | -2.56x | $-59.52 Million | $23.26 Million | ▼ -224.2% |
| 2019 | 2.06x | $55.22 Million | $26.81 Million | ▲ +188.5% |
| 2018 | -2.33x | $-44.08 Million | $18.93 Million | ▼ -59.9% |
| 2017 | -1.46x | $-22.09 Million | $15.17 Million | ▼ -253.8% |
| 2016 | -0.41x | $-5.65 Million | $13.72 Million | ▼ -108.3% |
| 2015 | 4.96x | $44.08 Million | $8.89 Million | ▲ +292.2% |
| 2014 | -2.58x | $-17.62 Million | $6.83 Million | ▼ -2.8% |
| 2013 | -2.51x | $-19.80 Million | $7.89 Million | — |